• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Challenges in the Diagnosis and Management of Bacterial Lung Infections in Solid Organ Recipients: A Narrative Review.实体器官受者细菌性肺部感染的诊断与管理难点:叙述性综述。
Int J Mol Sci. 2020 Feb 12;21(4):1221. doi: 10.3390/ijms21041221.
2
Antimicrobial stewardship by academic detailing improves antimicrobial prescribing in solid organ transplant patients.学术强化策略可改善实体器官移植患者的抗菌药物处方。
Eur J Clin Microbiol Infect Dis. 2019 Oct;38(10):1915-1923. doi: 10.1007/s10096-019-03626-8. Epub 2019 Jul 19.
3
Antimicrobial stewardship programs in solid-organ transplant recipients in Switzerland.瑞士实体器官移植受者的抗菌药物管理项目。
Transpl Infect Dis. 2022 Oct;24(5):e13902. doi: 10.1111/tid.13902.
4
Antimicrobial stewardship in solid organ transplant recipients: Current challenges and proposed metrics.实体器官移植受者中的抗菌药物管理:当前的挑战和建议的衡量标准。
Transpl Infect Dis. 2022 Oct;24(5):e13883. doi: 10.1111/tid.13883.
5
Opportunities for Antimicrobial Stewardship Interventions Among Solid Organ Transplant Recipients.实体器官移植受者中抗菌药物管理干预的机会。
Infect Dis Clin North Am. 2023 Sep;37(3):539-560. doi: 10.1016/j.idc.2023.04.005. Epub 2023 Jun 4.
6
Importance of antimicrobial stewardship in solid organ transplant recipients: An ESCMID perspective.实体器官移植受者中抗菌药物管理的重要性:ESCMID 视角。
Transpl Infect Dis. 2022 Oct;24(5):e13852. doi: 10.1111/tid.13852.
7
Antimicrobial resistance in cystic fibrosis: Does it matter?囊性纤维化中的抗菌药物耐药性:有关系吗?
J Cyst Fibros. 2018 Nov;17(6):687-689. doi: 10.1016/j.jcf.2018.08.015. Epub 2018 Sep 27.
8
Multidrug-resistant bacterial infection in solid organ transplant recipients.实体器官移植受者的多重耐药菌感染。
Enferm Infecc Microbiol Clin. 2012 Mar;30 Suppl 2:40-8. doi: 10.1016/S0213-005X(12)70081-2.
9
Opportunistic Pulmonary Infections in the Solid Organ Transplant Recipient: A Focus on Drug Therapy.实体器官移植受者的机会性肺部感染:聚焦药物治疗
Crit Care Nurs Q. 2017 Oct/Dec;40(4):399-413. doi: 10.1097/CNQ.0000000000000176.
10
Embracing Procalcitonin for Antimicrobial Stewardship.采用降钙素原进行抗菌药物管理。
J Appl Lab Med. 2019 Jan;3(4):712-715. doi: 10.1373/jalm.2018.026385. Epub 2018 Nov 20.

引用本文的文献

1
Recommendations on Rapid Diagnostic Point-of-care Molecular Tests for Respiratory Infections in the United Arab Emirates.阿拉伯联合酋长国呼吸道感染快速诊断即时分子检测建议
Open Respir Med J. 2024 Dec 17;18:e18743064319029. doi: 10.2174/0118743064319029240815074449. eCollection 2024.
2
Multisite biologic tissue SARS-CoV-2 PCR testing in kidney transplantation from a COVID-positive donor.来自新冠病毒检测呈阳性供体的肾脏移植中多部位生物组织的新冠病毒2型聚合酶链式反应检测
J Surg Case Rep. 2022 Jul 5;2022(7):rjac314. doi: 10.1093/jscr/rjac314. eCollection 2022 Jul.
3
The Airway Microbiota Signatures of Infection and Rejection in Lung Transplant Recipients.肺移植受者中感染和排斥反应的气道微生物群特征。
Microbiol Spectr. 2022 Apr 27;10(2):e0034421. doi: 10.1128/spectrum.00344-21. Epub 2022 Apr 13.
4
Divergent airway microbiomes in lung transplant recipients with or without pulmonary infection.肺移植受者中有无肺部感染的气道微生物组存在差异。
Respir Res. 2021 Apr 23;22(1):118. doi: 10.1186/s12931-021-01724-w.
5
Dealing With Liver Transplantation during Coronavirus Disease 2019 Pandemic: Normothermic Machine Perfusion Enables for Donor, Organ, and Recipient Assessment: A Case Report.应对2019冠状病毒病大流行期间的肝移植:常温机器灌注有助于供体、器官和受体评估:一例报告
Transplant Proc. 2020 Nov;52(9):2707-2710. doi: 10.1016/j.transproceed.2020.07.011. Epub 2020 Jul 22.

本文引用的文献

1
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study.产碳青霉烯酶肠杆菌科定植对肝移植后感染风险的影响:一项前瞻性观察队列研究。
Clin Microbiol Infect. 2019 Dec;25(12):1525-1531. doi: 10.1016/j.cmi.2019.04.014. Epub 2019 Apr 27.
2
Invasive Fungal Infection After Lung Transplantation: Epidemiology in the Setting of Antifungal Prophylaxis.肺移植后侵袭性真菌感染:抗真菌预防背景下的流行病学。
Clin Infect Dis. 2020 Jan 1;70(1):30-39. doi: 10.1093/cid/ciz156.
3
Viral Respiratory Tract Infection During the First Postoperative Year Is a Risk Factor for Chronic Rejection After Lung Transplantation.术后第一年发生的病毒性呼吸道感染是肺移植后慢性排斥反应的一个危险因素。
Transplant Direct. 2018 Jul 11;4(8):e370. doi: 10.1097/TXD.0000000000000808. eCollection 2018 Aug.
4
Risk factors for infection after pediatric lung transplantation.小儿肺移植术后感染的危险因素。
Transpl Infect Dis. 2018 Dec;20(6):e13000. doi: 10.1111/tid.13000. Epub 2018 Oct 5.
5
Microbiological findings in bronchoalveolar lavage fluid from lung transplant patients in Sweden.瑞典肺移植患者支气管肺泡灌洗 fluid 的微生物学研究结果 。(注:这里“fluid”结合语境推测可能是“液体”,但原英文表述不太准确完整)
Transpl Infect Dis. 2018 Dec;20(6):e12973. doi: 10.1111/tid.12973. Epub 2018 Aug 27.
6
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae.头孢他啶-阿维巴坦挽救治疗产碳青霉烯酶肺炎克雷伯菌引起的感染患者的疗效。
Clin Infect Dis. 2019 Jan 18;68(3):355-364. doi: 10.1093/cid/ciy492.
7
Activity of Plazomicin against Gram-Negative and Gram-Positive Isolates Collected from U.S. Hospitals and Comparative Activities of Aminoglycosides against Carbapenem-Resistant Enterobacteriaceae and Isolates Carrying Carbapenemase Genes.帕拉米韦对美国医院分离的革兰氏阴性和革兰氏阳性菌的活性及氨基糖苷类药物对碳青霉烯类耐药肠杆菌科和产碳青霉烯酶基因的分离株的比较活性。
Antimicrob Agents Chemother. 2018 Jul 27;62(8). doi: 10.1128/AAC.00313-18. Print 2018 Aug.
8
Nontuberculous mycobacterial and Aspergillus infections among cadaveric lung transplant recipients in Japan.日本尸体肺移植受者中的非结核分枝杆菌和曲霉感染。
Respir Investig. 2018 May;56(3):243-248. doi: 10.1016/j.resinv.2017.12.010. Epub 2018 Feb 4.
9
Early Bacterial Pneumonia After Hepatic Transplantation: Epidemiologic Profile.肝移植术后早期细菌性肺炎:流行病学概况
Transplant Proc. 2018 Mar;50(2):503-508. doi: 10.1016/j.transproceed.2017.11.047.
10
Future Research Directions in Pneumonia. NHLBI Working Group Report.肺炎的未来研究方向。NHLBI 工作组报告。
Am J Respir Crit Care Med. 2018 Jul 15;198(2):256-263. doi: 10.1164/rccm.201801-0139WS.

实体器官受者细菌性肺部感染的诊断与管理难点:叙述性综述。

Challenges in the Diagnosis and Management of Bacterial Lung Infections in Solid Organ Recipients: A Narrative Review.

机构信息

Internal Medicine Department, Division of Infectious Diseases, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico Milano, 20122 Milano, Italy.

Division of Infectious Diseases and International Health, Duke University, Durham, NC 27710, USA.

出版信息

Int J Mol Sci. 2020 Feb 12;21(4):1221. doi: 10.3390/ijms21041221.

DOI:10.3390/ijms21041221
PMID:32059371
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7072844/
Abstract

Respiratory infections pose a significant threat to the success of solid organ transplantation, and the diagnosis and management of these infections are challenging. The current narrative review addressed some of these challenges, based on evidence from the literature published in the last 20 years. Specifically, we focused our attention on (i) the obstacles to an etiologic diagnosis of respiratory infections among solid organ transplant recipients, (ii) the management of bacterial respiratory infections in an era characterized by increased antimicrobial resistance, and (iii) the development of antimicrobial stewardship programs dedicated to solid organ transplant recipients.

摘要

呼吸道感染对实体器官移植的成功构成重大威胁,这些感染的诊断和管理具有挑战性。本综述性叙述基于过去 20 年发表的文献中的证据,探讨了其中的一些挑战。具体而言,我们专注于:(i) 实体器官移植受者呼吸道感染病因诊断的障碍,(ii) 耐抗生素细菌引起的呼吸道感染的管理,以及 (iii) 制定专门针对实体器官移植受者的抗菌药物管理计划。